Publications

For a full bibliography, please visit PubMed

Selected Publications

Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults.

Samandari T, Ongalo JB, McCarthy KD, Biegon RK, Madiega PA, Mithika A, Orinda J, Mboya GM, Mwaura P, Anzala O, Onyango C, Oluoch FO, Osoro E, Dutertre CA, Tan N, Hang SK, Hariharaputran S, Lye DC, Herman-Roloff A, Le Bert N, Bertoletti A. Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults. J Clin Invest. 2023 Jul 3;133(13):e170011. doi: 10.1172/JCI170011.
An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial.

Kalimuddin S, Chan YFZ, Sessions OM, Chan KR, Ong EZ, Low JG, Bertoletti A, Ooi EE. An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial. Front Immunol. 2023 Mar 10;14:1135979. doi: 10.3389/fimmu.2023.1135979.
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma.

Lam MSY, Reales-Calderon JA, Ow JR, Aw JJY, Tan D, Vijayakumar R, Ceccarello E, Tabaglio T, Lim YT, Chien WL, Lai F, Tanoto AT, Chen Q, Sobota RM, Adriani G, Bertoletti A, Guccione E, Pavesi A. G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nat Commun. 2023 Feb 2;14(1):563. doi: 10.1038/s41467-023-36160-5.